NAM
GSK icon

NTV Asset Management’s GSK GSK Stock Holding History

NTV Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Sell
4,464
-166
-4% -$8.99K 0.03% 279
2025
Q4 		$227K Buy
+4,630
New +$216K 0.02% 287
2024
Q4 		– Sell
-5,204
Closed -$213K – 276
2024
Q3 		$213K Sell
5,204
-40
-0.8% -$1.64K 0.03% 256
2024
Q2 		$202K Sell
5,244
-280
-5% -$11.8K 0.03% 254
2024
Q1 		$237K Hold
5,524
– – 0.04% 229
2023
Q4 		$205K Hold
5,524
– – 0.03% 242
2023
Q3 		$200K Buy
+5,524
New +$196K 0.04% 247
2022
Q2 		– Sell
-6,637
Closed -$361K – 253
2022
Q1 		$361K Hold
6,637
– – 0.06% 189
2021
Q4 		$366K Sell
6,637
-1,180
-15% -$61.4K 0.06% 189
2021
Q3 		$373K Buy
7,817
+727
+10% +$36.5K 0.06% 182
2021
Q2 		$353K Sell
7,090
-1,600
-18% -$76.9K 0.06% 181
2021
Q1 		$388K Sell
8,690
-1,108
-11% -$50.3K 0.07% 158
2020
Q4 		$451K Sell
9,798
-2,596
-21% -$119K 0.09% 137
2020
Q3 		$583K Buy
12,394
+56
+0.5% +$2.81K 0.14% 113
2020
Q2 		$629K Sell
12,338
-1,080
-8% -$55.4K 0.16% 109
2020
Q1 		$635K Buy
13,418
+248
+2% +$13.2K 0.21% 99
2019
Q4 		$774K Buy
13,170
+940
+8% +$52.3K 0.2% 101
2019
Q3 		$652K Buy
12,230
+200
+2% +$10.3K 0.19% 105
2019
Q2 		$602K Sell
12,030
-320
-3% -$16.1K 0.17% 108
2019
Q1 		$645K Sell
12,350
-320
-3% -$16K 0.18% 109
2018
Q4 		$605K Sell
12,670
-160
-1% -$7.88K 0.2% 106
2018
Q3 		$644K Sell
12,830
-3,120
-20% -$159K 0.17% 115
2018
Q2 		$804K Hold
15,950
– – 0.23% 109
2018
Q1 		$779K Hold
15,950
– – 0.22% 110
2017
Q4 		$707K Sell
15,950
-4,920
-24% -$227K 0.2% 110
2017
Q3 		$1.06M Sell
20,870
-3,760
-15% -$191K 0.31% 90
2017
Q2 		$1.33M Buy
24,630
+320
+1% +$17.1K 0.4% 73
2017
Q1 		$1.28M Sell
24,310
-240
-1% -$12.2K 0.41% 76
2016
Q4 		$1.18M Sell
24,550
-1,280
-5% -$63.2K 0.41% 72
2016
Q3 		$1.39M Buy
25,830
+920
+4% +$50.4K 0.5% 63
2016
Q2 		$1.35M Buy
24,910
+80
+0.3% +$4.21K 0.51% 60
2016
Q1 		$1.26M Buy
24,830
+160
+0.6% +$7.97K 0.48% 63
2015
Q4 		$1.24M Sell
24,670
-9,680
-28% -$493K 0.49% 59
2015
Q3 		$1.65M Sell
34,350
-8
-0% -$416 0.54% 57
2015
Q2 		$1.79M Sell
34,358
-237
-0.7% -$13.3K 0.52% 58
2015
Q1 		$2M Buy
34,595
+562
+2% +$32.2K 0.59% 50
2014
Q4 		$1.82M Sell
34,033
-997
-3% -$55.8K 0.54% 58
2014
Q3 		$2.01M Buy
35,030
+1,120
+3% +$68.7K 0.61% 50
2014
Q2 		$2.27M Buy
33,910
+8,880
+35% +$601K 0.69% 46
2014
Q1 		$1.67M Hold
25,030
– – 0.54% 61
2013
Q4 		$1.67M Buy
25,030
+320
+1% +$20.7K 0.57% 55
2013
Q3 		$1.55M Buy
24,710
+400
+2% +$25.7K 0.54% 58
2013
Q2 		$1.52M Buy
+24,310
New +$1.54M 0.55% 57

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NTV Asset Management's GSK Position: Q1 2026 in Review

NTV Asset Management reduced its GSK (GSK) stake by 3.6% in Q1 2026, selling an estimated $8.99K and leaving 4,464 shares worth $246K. The position accounts for 0.03% of the portfolio, ranked #279.

NTV Asset Management first reported a position in GSK in Q2 2013 and has held it in 43 quarters since. The position peaked at $2.27M in Q2 2014. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • NTV Asset Management held 4,464 shares of GSK worth $246K as of Q1 2026.
  • NTV Asset Management sold 166 GSK shares in Q1 2026, an estimated $8.99K.
  • GSK made up 0.03% of NTV Asset Management's portfolio in Q1 2026, its #279 holding.
  • NTV Asset Management first reported a position in GSK in Q2 2013 and has held it in 43 quarters since.
  • NTV Asset Management's GSK position peaked at $2.27M in Q2 2014.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.